Nordea Investment Management AB trimmed its holdings in CVS Health Co. (NYSE:CVS - Free Report) by 23.3% in the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 5,211,224 shares of the pharmacy operator's stock after selling 1,579,558 shares during the quarter. Nordea Investment Management AB owned 0.41% of CVS Health worth $233,671,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently made changes to their positions in the company. MidAtlantic Capital Management Inc. purchased a new stake in CVS Health in the 3rd quarter worth approximately $25,000. Livelsberger Financial Advisory bought a new stake in CVS Health in the third quarter valued at $31,000. Legacy Investment Solutions LLC purchased a new position in CVS Health during the 3rd quarter valued at $31,000. Reston Wealth Management LLC bought a new position in CVS Health in the 3rd quarter worth $32,000. Finally, Kathleen S. Wright Associates Inc. purchased a new stake in shares of CVS Health in the 3rd quarter worth about $33,000. Institutional investors own 80.66% of the company's stock.
CVS Health Stock Performance
CVS traded up $0.01 during mid-day trading on Tuesday, reaching $45.83. 10,241,564 shares of the company traded hands, compared to its average volume of 12,382,834. The company's fifty day moving average price is $52.40 and its 200-day moving average price is $56.86. The stock has a market capitalization of $57.67 billion, a P/E ratio of 11.63, a P/E/G ratio of 0.85 and a beta of 0.59. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. CVS Health Co. has a 52-week low of $43.56 and a 52-week high of $83.25.
CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, beating analysts' consensus estimates of $1.08 by $0.01. The company had revenue of $95.43 billion during the quarter, compared to analysts' expectations of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. CVS Health's revenue for the quarter was up 6.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $2.21 earnings per share. On average, sell-side analysts expect that CVS Health Co. will post 5.32 EPS for the current year.
CVS Health Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be paid a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 5.80%. The ex-dividend date is Thursday, January 23rd. CVS Health's dividend payout ratio is presently 67.51%.
Analyst Ratings Changes
CVS has been the subject of a number of research reports. Royal Bank of Canada lowered their price objective on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating for the company in a report on Friday, November 15th. TD Cowen raised their target price on CVS Health from $73.00 to $80.00 and gave the company a "buy" rating in a research note on Monday, November 25th. Barclays reduced their price target on CVS Health from $75.00 to $71.00 and set an "overweight" rating on the stock in a research note on Thursday, November 7th. Wells Fargo & Company raised CVS Health from an "equal weight" rating to an "overweight" rating and raised their price objective for the company from $60.00 to $66.00 in a research report on Monday, November 18th. Finally, Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a "hold" rating to a "buy" rating and set a $66.00 target price on the stock in a research report on Tuesday, December 3rd. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $68.71.
View Our Latest Stock Analysis on CVS Health
CVS Health Company Profile
(
Free Report)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Stories
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
